Get started
Author

Hana Abdullah Alabdulkarim

Observed names: Al Abdulkarim, Hana, Al-Abdulkarim, Hana, Alabdulkarim, Hana, Alabdulkarim, Hana Abdullah, H Alabdulkarim, H. Al-Abdulkarim, H. Alabdulkarim, H.A. Al-Abdulkarim, H.A.A. Alabdulkarim, HA Al-Abdulkarim, Hana A Al-Abdulkarim, Hana A. Al-Abdulkarim, Hana A. Alabdulkarim, Hana Abdullah Al-Abdulkarim, Hana Al Abdulkarim, Hana Al-Abdulkarim, Hana AlAbdalkarim, Hana Alabdulkareem, Hana Alabdulkarim
Institutions: Obuda University, King Saud bin Abdulaziz University for Health Sciences, Nanjing General Hospital of Nanjing Military Command, King Abdulaziz Medical City, King Abdullah International Medical Research Center, National Guard Health Affairs
Observed institutions: Obuda University, King Saud bin Abdulaziz University for Health Sciences, Nanjing General Hospital of Nanjing Military Command, King Abdulaziz Medical City, King Abdullah International Medical Research Center, Ministry of Defense, National Guard Health Affairs
ORCID: 0000-0002-5502-8743
Observed ORCID: 0000-0002-5502-8743
OpenAlex ID: A5029982314
The economic burden of overweight and obesity in Saudi Arabia
2022 · Jesse D. Malkin, Drishti Baid, et al. · PLoS ONE · 64
PDF
Healthcare systems and health economics in GCC countries: informing decision-makers from the perspective of the Gulf health economics association
2025 · Yazed AlRuthia, Sara Aldallal, et al. · Frontiers in Public Health · 51
A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities
2024 · Hussain A. Al-Omar, Ali Alshehri, et al. · Saudi Pharmaceutical Journal · 39
Digital Biomarker–Based Interventions: Systematic Review of Systematic Reviews
2022 · Hossein Motahari-Nezhad, Hana Al-Abdulkarim, et al. · Journal of Medical Internet Research · 35
PDF
Informing a cost-effectiveness threshold for Saudi Arabia
2022 · Ahmed Hamdan Al-Jedai, James Lomas, et al. · Journal of Medical Economics · 30
PDF
Obesity Burden and Impact of Weight Loss in Saudi Arabia: A Modelling Study
2023 · Saleh A. Alqahtani, Hussain A. Al-Omar, et al. · Advances in Therapy · 21
PDF
Humanistic and Economic Burden of Atopic Dermatitis for Adults and Adolescents in the Middle East and Africa Region
2022 · Baher Elezbawy, Ahmad Nader Fasseeh, et al. · Dermatology and Therapy · 20
PDF
Cancer Management in Saudi Arabia: Recommendations by the Saudi Oncology HeAlth Economics ExpeRt GrouP (SHARP)
2020 · Nora Alkhudair, Majed Alshamrani, et al. · Saudi Pharmaceutical Journal · 18
PDF
The Impact of Obesity in Saudi Arabia: Healthcare Resource Use and Costs Associated with Obesity-Related Complications
2023 · Hussain A. Al-Omar, Ali Alshehri, et al. · Advances in Therapy · 17
PDF
Fixed dose combinations: A formulary decision guide
2021 · Laila Carolina Abu Esba, Consuela Yousef, et al. · Health Policy and Technology · 17
PDF
Disease-Related Costs Published in The Middle East and North Africa Region: Systematic Review and Analysis of Transferability
2022 · Zsombor Zrubka, Márta Péntek, et al. · PharmacoEconomics · 15
PDF
An Institutional Guide for Formulary Decisions of Biosimilars
2022 · Sherin Ismail, Laila Abu Esba, et al. · Hospital Pharmacy · 14
Rare disease challenges and potential actions in the Middle East
2025 · Ahmad Nader Fasseeh, Nada Korra, et al. · International Journal for Equity in Health · 13
Respiratory Syncytial Virus (RSV) Burden in Infants in the Kingdom of Saudi Arabia and the Impact of All-Infant RSV Protection: A Modeling Study
2024 · Adel Alharbi, Abdullah Yousef, et al. · Advances in Therapy · 12
PDF
A Step Toward the Development of the First National Multi-Criteria Decision Analysis Framework to Support Healthcare Decision Making in Saudi Arabia
2024 · Ahmed Al-Jedai, Hajer Almudaiheem, et al. · Value in Health Regional Issues · 12
PDF
Real-World Impact of Switching From Insulin Glargine (Lantus®) to Basaglar® and Potential Cost Saving in a Large Public Healthcare System in Saudi Arabia
2022 · Yazed AlRuthia, Ohud H. Bahari, et al. · Frontiers in Public Health · 12
PDF
COVID-19 and Saudi Arabia public financing of prescription drugs: An opportunity for reform
2020 · Yazed AlRuthia, Sulaiman A. Alrashed, et al. · Health Policy and Technology · 12
The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia
2022 · Baher Elezbawy, Ahmad Nader Fasseeh, et al. · Journal of Medical Economics · 11
Global Economic Burden of Spinal Muscular Atrophy: A Systematic Literature Review
2025 · Rawda Elshahawy, Baher Elezbawy, et al. · Cureus · 9
Cost-efficiency analysis of conversion to biosimilar filgrastim for supportive cancer care and resultant expanded access analysis to supportive care and early-stage HER2+ breast cancer treatment in Saudi Arabia: simulation study
2023 · Consuela Cheriece Yousef, Mansoor Ahmed Khan, et al. · Journal of Medical Economics · 8
PDF
Pharmacy and Therapeutics Committee Preparedness Plan for COVID-19
2020 · Laila Carolina Abu Esba, Hana Abdullah Al-Abdulkarim, et al. · Global Journal on Quality and Safety in Healthcare · 8
Cost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia
2024 · Hana Al-Abdulkarim, Yuvraj Sharma, et al. · Journal of Medical Economics · 7
PDF
Outcomes of continuous glucose monitoring: Protocol for A Systematic Review of Systematic Reviews
2022 · Hana Alabdulkarim · IEEE International Symposium on Intelligent Systems and Informatics (SISY) · 5
Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre- or Post-Vaccination: A Descriptive Study of a Nationally Representative Sample in Saudi Arabia
2022 · Yazed AlRuthia, Haya F. Al-Salloum, et al. · Vaccines · 5
PDF
A Formulary Management Group Consensus
2024 · Laila Carolina Abu Esba, Hind Almodaimegh, et al. · Global Journal on Quality and Safety in Healthcare · 4
PDF
Works count: 74
Citation count: 493
H-index: 13
I10-index: 18
Year
Topic
Type